APA aipamena

Wang, L., Kang, F., Wang, J., Yang, C., & He, D. (2019). Downregulation of miR-205 contributes to epithelial–mesenchymal transition and invasion in triple-negative breast cancer by targeting HMGB1–RAGE signaling pathway. Anticancer Drugs.

Chicago Style aipamena

Wang, Ling, Fu-biao Kang, Juan Wang, Chao Yang, and Dong-wei He. "Downregulation of MiR-205 Contributes to Epithelial–mesenchymal Transition and Invasion in Triple-negative Breast Cancer By Targeting HMGB1–RAGE Signaling Pathway." Anticancer Drugs 2019.

MLA aipamena

Wang, Ling, et al. "Downregulation of MiR-205 Contributes to Epithelial–mesenchymal Transition and Invasion in Triple-negative Breast Cancer By Targeting HMGB1–RAGE Signaling Pathway." Anticancer Drugs 2019.